Status:
UNKNOWN
Primary Prevention of Cytomegalovirus in Pregnancy: Addressing the Gaps (CMV GAP)
Lead Sponsor:
University Hospital Southampton NHS Foundation Trust
Collaborating Sponsors:
St George's, University of London
University College, London
Conditions:
Cytomegalovirus Congenital
Eligibility:
FEMALE
Brief Summary
CMV is the most common congenital infection (an infection acquired before birth) in the UK. It is the leading non-genetic cause of sensorineural (inner ear) hearing loss and a common cause of neuro-di...
Detailed Description
Ten children are born every day in the UK with congenital cytomegalovirus (CMV) infection. Over half of infants who have symptoms or signs of CMV at birth have moderate to severe long-term impairments...
Eligibility Criteria
Inclusion
- Antenatal sera collected in the designated sites within the first 16 weeks of pregnancy and collected within a two-month period between 1st April 2019 and 1st October 2019 inclusive.
Exclusion
- There are no exclusion criteria other than inability to fulfil the inclusion criteria above.
Key Trial Info
Start Date :
May 3 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2021
Estimated Enrollment :
6000 Patients enrolled
Trial Details
Trial ID
NCT04879784
Start Date
May 3 2021
End Date
December 31 2021
Last Update
May 12 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.